These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16586498)

  • 41. LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
    Natkunam Y; Farinha P; Hsi ED; Hans CP; Tibshirani R; Sehn LH; Connors JM; Gratzinger D; Rosado M; Zhao S; Pohlman B; Wongchaowart N; Bast M; Avigdor A; Schiby G; Nagler A; Byrne GE; Levy R; Gascoyne RD; Lossos IS
    J Clin Oncol; 2008 Jan; 26(3):447-54. PubMed ID: 18086797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survival of patients with blood-borne AIDS in Italy.
    Bellocco R; Xu J; Schinaia N; Arcieri R; Pagano M
    J Epidemiol Biostat; 2000; 5(2):79-87. PubMed ID: 10890279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998.
    Fuller CD; Wang SJ; Thomas CR; Hoffman HT; Weber RS; Rosenthal DI
    Cancer; 2007 Apr; 109(7):1331-43. PubMed ID: 17326199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma.
    Hasselblom S; Sigurdadottir M; Hansson U; Nilsson-Ehle H; Ridell B; Andersson PO
    Br J Haematol; 2007 May; 137(4):364-73. PubMed ID: 17456059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis.
    Ballonoff A; Rusthoven KE; Schwer A; McCammon R; Kavanagh B; Bassetti M; Newman F; Rabinovitch R
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1465-71. PubMed ID: 18495371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation?
    Krishnan A; Nademanee A; Fung H; Angelopoulou M; Molina A; Gaal K; Dagis A; Palmer J; Alvarnas J; Slovak M; Kogut N; Popplewell L; Rodriguez R; Schriber J; Wang S; Forman SJ
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):641-7. PubMed ID: 16737937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma.
    Imai H; Shimada K; Shimada S; Abe M; Okamoto M; Kitamura K; Kinoshita T; Shiraishi T; Nakamura S
    Pathol Int; 2009 Jul; 59(7):431-7. PubMed ID: 19563405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma.
    Jang KY; Hwang SH; Kwon KS; Kim KR; Choi HN; Lee NR; Kwak JY; Park BH; Park HS; Chung MJ; Kang MJ; Lee DG; Kim HS; Shim H; Moon WS
    Am J Surg Pathol; 2008 Oct; 32(10):1523-31. PubMed ID: 18724249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.
    Coso D; Sebban C; Boulat O; Biron P; Rey J; Aurran T; Chabannon C; Xerri L; Chetaille B; Esterni B; Ivanov V; Stoppa AM; Schiano de Collela JM; Gastaut JA; Maraninchi D; Bouabdallah R
    Bone Marrow Transplant; 2006 Aug; 38(3):217-22. PubMed ID: 16770316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation.
    Tandon P; Goodman KJ; Ma MM; Wong WW; Mason AL; Meeberg G; Bergsten D; Carbonneau M; Bain VG
    Am J Gastroenterol; 2009 Jul; 104(7):1700-6. PubMed ID: 19471253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
    Nyman H; Jerkeman M; Karjalainen-Lindsberg ML; Banham AH; Enblad G; Leppä S
    Eur J Haematol; 2009 May; 82(5):364-72. PubMed ID: 19141121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic factors in primary gastric lymphoma.
    Medina-Franco H; Germes SS; Maldonado CL
    Ann Surg Oncol; 2007 Aug; 14(8):2239-45. PubMed ID: 17546474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients.
    Beal K; Allen L; Yahalom J
    Cancer; 2006 Jun; 106(12):2652-6. PubMed ID: 16700039
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors.
    Validire P; Capovilla M; Asselain B; Kirova Y; Goudefroye R; Plancher C; Fourquet A; Zanni M; Gaulard P; Vincent-Salomon A; Decaudin D
    Am J Hematol; 2009 Mar; 84(3):133-9. PubMed ID: 19199367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.
    Weiss ES; Nwakanma LU; Patel ND; Yuh DD
    J Heart Lung Transplant; 2008 Feb; 27(2):184-91. PubMed ID: 18267225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphoma.
    Nola M; Pavletic SZ; Weisenburger DD; Smith LM; Bast MA; Vose JM; Armitage JO
    Am J Hematol; 2004 Sep; 77(1):31-5. PubMed ID: 15307103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.